Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Available at: Last updated 6/9/2015
Originally discovered by Chugai as OWL833 and later licensed by Eli Lilly as LY3502970, it was also selected for the FDAs National Priority Review Voucher pilot program
The FDA has explicitly stated it does not meet the requirements for compounding exemptions
[78] In other words, amphetamine induces competitive NET reuptake inhibition, TAAR1-mediated non-competitive reuptake inhibition and reverse transport at phosphorylated NET, CAMKII-mediated NET efflux independent of TAAR1, and norepinephrine release from VMAT2
US$ 20.52
US$ 21.85
US$ 28.89
US$ 20.72
US$ 29.41
US$ 20.96
US$ 21.16
US$ 29.46
